| Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers (NCT05047692) | Cellid Co., Ltd. | 2021-09-09 |
| A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation (NCT04973163) | Boehringer Ingelheim | 2021-09-09 |
| Copanlisib Plus Venetoclax in R/R DLBCL (NCT04572763) | Dana-Farber Cancer Institute | 2021-09-08 |
| Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation (NCT04890613) | Senhwa Biosciences, Inc. | 2021-09-08 |
| A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies (NCT04927884) | ImmunityBio, Inc. | 2021-09-08 |
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571) | National University Hospital, Singapore | 2021-09-08 |
| Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children (NCT04586504) | Columbia University | 2021-09-08 |
| A Study of LP-118 in Patients With Advanced Tumors (NCT05025358) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2021-09-08 |
| Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder (NCT05321602) | Luye Pharma Group Ltd. | 2021-09-08 |
| Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects (NCT05030857) | Lakefront Biotherapeutics NV | 2021-09-08 |
| A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial) (NCT04998396) | Aspa Therapeutics | 2021-09-08 |
| Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine (NCT04961541) | Novavax | 2021-09-08 |
| A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors (NCT05159388) | Servier Bio-Innovation LLC | 2021-09-08 |
| Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma (NCT04526834) | Tessa Therapeutics | 2021-09-08 |
| Evaluation of Oral PF614 Relative to OxyContin (PF614-102) (NCT05043766) | Ensysce Biosciences | 2021-09-08 |
| Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors (NCT04975958) | Adlai Nortye Biopharma Co., Ltd. | 2021-09-07 |
| Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy (NCT06665633) | Nova Southeastern University | 2021-09-07 |
| Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft (NCT05088356) | Stanford University | 2021-09-07 |
| A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 (NCT05047341) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-07 |
| A Study of Subcutaneous Lecanemab in Healthy Participants (NCT05045716) | Eisai Inc. | 2021-09-07 |
| A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis (NCT05011019) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-09-07 |
| A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects (NCT05041920) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-07 |
| Study of Intravenous Erenumab in Patients With Status Migrainosus (NCT04920331) | Mayo Clinic | 2021-09-07 |
| A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy (NCT05077137) | Duke University | 2021-09-07 |
| Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors (NCT05862831) | Biotheus Inc. | 2021-09-07 |
| A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (NCT05026593) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-09-07 |
| A Study of TAK-662 for Japanese Patients With Congenital Protein C Deficiency (NCT04984889) | Takeda | 2021-09-07 |
| Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment (NCT04971928) | GlaxoSmithKline | 2021-09-07 |
| A Study of A4368 in Healthy Subjects (NCT04932252) | Autophagy Sciences, Inc. | 2021-09-07 |
| Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (NCT05060432) | iTeos Belgium SA | 2021-09-06 |
| Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma (NCT05420493) | Chongqing Precision Biotech Co., Ltd | 2021-09-06 |
| Study of WVE-003 in Patients With Huntington's Disease (NCT05032196) | Wave Life Sciences USA, Inc. | 2021-09-06 |
| GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery (NCT04979832) | Zealand University Hospital | 2021-09-06 |
| Study to Evaluate the Safety and PK of UI018 (NCT05085184) | Korea United Pharm. Inc. | 2021-09-06 |
| Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians (NCT05005065) | HK inno.N Corporation | 2021-09-06 |
| Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. (NCT04843891) | Ralph Weissleder, MD | 2021-09-06 |
| First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 (NCT04993443) | Syneos Health | 2021-09-06 |
| A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People (NCT05046873) | Novo Nordisk A/S | 2021-09-06 |
| A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers (NCT05068193) | Boryung Pharmaceutical Co., Ltd | 2021-09-06 |
| A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years. (NCT05028608) | Bayer | 2021-09-06 |
| A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL). (NCT05156229) | Codiak BioSciences | 2021-09-06 |
| A Study On Human Mass Balance And Biotransformation (NCT05040113) | Connect Biopharm LLC | 2021-09-04 |
| Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations (NCT05103891) | Pierre Fabre Medicament | 2021-09-03 |
| Hydration Dynamics and Influence of Beverage Composition (NCT05111392) | University of Illinois at Chicago | 2021-09-03 |
| JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation (NCT05002270) | Jacobio Pharmaceuticals Co., Ltd. | 2021-09-03 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated (NCT04978506) | Boehringer Ingelheim | 2021-09-03 |
| A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations (NCT04994002) | Avalo Therapeutics, Inc. | 2021-09-03 |
| Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib (NCT04486833) | Genprex, Inc. | 2021-09-03 |
| A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (NCT04537377) | Vivet Therapeutics SAS | 2021-09-03 |
| A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis (NCT05442788) | Huabo Biopharm Co., Ltd. | 2021-09-02 |
| Post IVIG Medication in Children With Immune Thrombocytopenia (NCT04741139) | Baylor College of Medicine | 2021-09-02 |
| Pharmacokinetics of HR17031 Injection in Healthy Subjects (NCT05031871) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-02 |
| Open-label Study of Surufatinib in Japanese Patients (NCT05077384) | Hutchmed | 2021-09-02 |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC (NCT04959981) | Erasca, Inc. | 2021-09-02 |
| A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer (NCT05067140) | Novartis Pharmaceuticals | 2021-09-02 |
| Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients (NCT04981912) | University of California, San Diego | 2021-09-02 |
| Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors (NCT05148325) | Bio-Thera Solutions | 2021-09-02 |
| A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy (NCT04951609) | Janssen Research & Development, LLC | 2021-09-02 |
| Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID) (NCT03597594) | St. Jude Children's Research Hospital | 2021-09-02 |
| Allergic Disease Onset Prevention Study (NCT05003804) | Siolta Therapeutics, Inc. | 2021-09-01 |
| CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients (NCT03944902) | University of Alabama at Birmingham | 2021-09-01 |
| Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer (NCT04158635) | City of Hope Medical Center | 2021-09-01 |
| Antiplaque Efficacy of Two Novel Commercially Available Herbal Toothpastes. (NCT05363956) | Ajman University | 2021-09-01 |
| Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens (NCT05219669) | Opiant Pharmaceuticals Inc | 2021-09-01 |
| Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer (NCT05023928) | Sichuan University | 2021-09-01 |
| SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05020925) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-01 |
| Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study (NCT04906681) | PXL University College | 2021-09-01 |
| CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type (NCT05218408) | Celularity Incorporated | 2021-09-01 |
| Acute Changes In Thermal Pain Response Following Single Oral Dose of Beta-Cary (NCT04794205) | Hartford Hospital | 2021-09-01 |
| A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma (NCT04722601) | University of Chicago | 2021-09-01 |
| Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH (NCT04540380) | Massachusetts General Hospital | 2021-09-01 |
| Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas (NCT04774068) | Walter Hanel | 2021-09-01 |
| Effect of Preemptive Analgesia With Flurbiprofen Axetil on Perioperative Sleep Quality and Postoperative Pain in Patients Undergoing Laparoscopic Gynecological Surgery. (NCT04611763) | Beijing Friendship Hospital | 2021-09-01 |
| A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (NCT05010525) | Shanghai Antengene Corporation Limited | 2021-09-01 |
| A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers (NCT05024747) | HALEON | 2021-09-01 |
| Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication (NCT05003492) | Amr kamel khalil Ahmed | 2021-09-01 |
| A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19 (NCT05035576) | Optinose US Inc. | 2021-09-01 |
| Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium (NCT04283435) | Cairo University | 2021-09-01 |
| Gut Microbiota Reconstruction for NSCLC Immunotherapy (NCT05008861) | Shanghai Zhongshan Hospital | 2021-09-01 |
| A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor (NCT05015309) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2021-09-01 |
| Antibiotics Continuous Infusion at Home (NCT04816968) | Ospedale San Carlo Borromeo | 2021-09-01 |
| A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD) (NCT04662151) | Airway Therapeutics, Inc. | 2021-09-01 |
| A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers (NCT04973020) | Jiangsu HengRui Medicine Co., Ltd. | 2021-09-01 |
| Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks (NCT05610969) | University of Pennsylvania | 2021-09-01 |
| Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NCT04827953) | Nelum Corp | 2021-09-01 |
| Evaluation of Post-operative Pain and Expression of IL-8 Using Ketolac or Cryoirrigation as a Final Flush in Single Visit Endodontic Treatment in Teeth With Symptomatic Irreversible Pulpitis and Apical Periodontitis.Randomized Clinical Trial. (NCT04733326) | Cairo University | 2021-09-01 |
| Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma (NCT05013268) | Ruijin Hospital | 2021-09-01 |
| Efficacy of Ivermectin in COVID-19 (NCT05076253) | Bangkok Metropolitan Administration Medical College and Vajira Hospital | 2021-09-01 |
| To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue (NCT04593758) | Cornerstone Pharmaceuticals | 2021-09-01 |
| Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS (NCT04749433) | Johns Hopkins University | 2021-09-01 |
| A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy (NCT04814875) | THERAPIM PTY LTD | 2021-09-01 |
| Salt-Sensitivity and Immunity Cell Activation (NCT03753204) | Vanderbilt University Medical Center | 2021-09-01 |
| INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees (NCT04906629) | University of Geneva, Switzerland | 2021-09-01 |
| Plexin B2 Gene Expression and Polymorphisms in Psoriasis (NCT05184348) | South Valley University | 2021-09-01 |
| Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer (NCT05120622) | University of British Columbia | 2021-09-01 |
| Mesenchymal Stem Cells for The Treatment of Frailty Syndrome (NCT04914403) | Meridigen Biotech Co., Ltd. | 2021-09-01 |
| PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers (NCT04941781) | Contineum Therapeutics | 2021-09-01 |
| The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC (NCT05042336) | Sichuan University | 2021-09-01 |
| Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) (NCT04809623) | Gilead Sciences | 2021-09-01 |
| A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa. (NCT05286567) | Aarhus University Hospital | 2021-09-01 |